Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Johnson & Johnson, consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

	Sep 28, 2025	Jun 29, 2025	Mar 30, 2025	Dec 29, 2024	Sep 29, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Oct 1, 2023	Jul 2, 2023	Apr 2, 2023	Dec 31, 2022	Oct 2, 2022	Jul 3, 2022	Apr 3, 2022	Dec 31, 2021	Oct 3, 2021	Jul 4, 2021	Apr 4, 2021	Dec 31, 2020	Sep 27, 2020	Jun 28, 2020	Mar 29, 2020
Loans and notes payable	6,387)	11,526)	13,897)	5,983)	4,462)	9,855)	8,550)	3,451)	3,870)	11,701)	17,979)	12,771)	4,424)	4,305)	4,297)	3,766)	3,798)	3,173)	3,350)	2,631)	5,078)	5,332)	2,190)
Accounts payable	9,625)	9,464)	9,545)	10,311)	8,954)	8,848)	8,174)	9,632)	8,355)	10,443)	9,909)	11,703)	10,153)	9,765)	9,309)	11,055)	8,961)	8,704)	8,503)	9,505)	7,044)	6,765)	7,411)
Accrued liabilities	7,601)	7,404)	7,913)	8,549)	11,450)	10,539)	10,323)	10,212)	10,101)	10,605)	11,204)	11,456)	11,953)	12,607)	13,006)	13,612)	13,812)	10,485)	13,223)	13,968)	9,629)	8,940)	8,384)
Accrued rebates, returns and promotions	21,356)	20,823)	18,780)	17,580)	18,439)	17,539)	16,182)	16,001)	15,808)	15,672)	14,784)	14,417)	14,021)	13,447)	12,972)	12,095)	12,683)	12,450)	11,919)	11,513)	12,418)	11,790)	11,608)
Accrued compensation and employee related obligations	3,972)	3,298)	2,551)	4,126)	3,620)	2,843)	2,178)	3,993)	3,337)	3,062)	2,231)	3,328)	3,006)	2,717)	2,098)	3,586)	3,146)	2,709)	2,060)	3,484)	3,012)	2,313)	2,166)
Accrued taxes on income	1,928)	1,665)	4,217)	3,772)	4,834)	4,309)	3,318)	2,993)	2,899)	2,687)	4,266)	2,127)	1,986)	1,980)	1,708)	1,112)	2,161)	1,200)	1,877)	1,392)	1,666)	1,632)	1,930)
Current liabilities	50,869)	54,180)	56,903)	50,321)	51,759)	53,933)	48,725)	46,282)	44,370)	54,170)	60,373)	55,802)	45,543)	44,821)	43,390)	45,226)	44,561)	38,721)	40,932)	42,493)	38,847)	36,772)	33,689)
Long-term debt, excluding current portion	39,408)	39,235)	38,355)	30,651)	31,289)	31,636)	25,082)	25,881)	26,051)	33,901)	34,928)	26,888)	27,603)	28,292)	28,851)	29,985)	30,130)	30,310)	30,263)	32,635)	32,680)	25,062)	25,393)
Deferred taxes on income	5,988)	3,799)	2,428)	2,448)	2,952)	2,635)	3,172)	3,193)	2,623)	3,627)	4,417)	6,374)	4,946)	5,015)	6,424)	7,487)	7,147)	9,016)	6,507)	7,214)	5,615)	5,532)	5,766)
Employee related obligations	6,930)	7,021)	7,046)	7,255)	6,852)	6,919)	7,019)	7,149)	5,687)	6,461)	6,665)	6,767)	8,353)	8,553)	8,739)	8,898)	10,171)	10,367)	10,512)	10,771)	10,184)	10,411)	10,529)
Long-term taxes payable	418)	418)	395)	390)	354)	341)	2,881)	2,881)	2,540)	2,536)	4,296)	4,306)	4,162)	4,162)	5,745)	5,713)	5,770)	5,722)	6,568)	6,559)	6,745)	6,591)	7,402)
Other liabilities	9,926)	10,263)	10,435)	17,549)	14,923)	14,086)	15,067)	13,398)	13,562)	14,582)	14,421)	10,437)	9,918)	10,524)	10,497)	10,686)	11,177)	12,724)	11,941)	11,944)	12,149)	11,034)	10,944)
Non-current liabilities	62,670)	60,736)	58,659)	58,293)	56,370)	55,617)	53,221)	52,502)	50,463)	61,107)	64,727)	54,772)	54,982)	56,546)	60,256)	62,769)	64,395)	68,139)	65,791)	69,123)	67,373)	58,630)	60,034)
Total liabilities	113,539)	114,916)	115,562)	108,614)	108,129)	109,550)	101,946)	98,784)	94,833)	115,277)	125,100)	110,574)	100,525)	101,367)	103,646)	107,995)	108,956)	106,860)	106,723)	111,616)	106,220)	95,402)	93,723)
Common stock, par value $1.00 per share	3,120)	3,120)	3,120)	3,120)	3,120)	3,120)	3,120)	3,120)	3,120)	3,120)	3,120)	3,120)	3,120)	3,120)	3,120)	3,120)	3,120)	3,120)	3,120)	3,120)	3,120)	3,120)	3,120)
Accumulated other comprehensive loss	(15,237)	(14,305)	(11,740)	(11,741)	(12,522)	(11,253)	(10,768)	(12,527)	(8,780)	(13,135)	(12,626)	(12,967)	(15,292)	(13,843)	(13,757)	(13,058)	(15,415)	(15,100)	(15,328)	(15,242)	(14,938)	(15,533)	(16,243)
Retained earnings and Additional paid-in capital	167,281)	165,371)	162,635)	155,791)	155,179)	155,360)	153,378)	153,843)	152,536)	129,381)	124,558)	128,345)	127,917)	126,216)	124,380)	123,060)	121,092)	120,154)	116,508)	113,890)	114,831)	113,898)	112,901)
Common stock held in treasury, at cost	(75,887)	(75,713)	(75,906)	(75,680)	(75,619)	(75,689)	(75,710)	(75,662)	(75,648)	(44,217)	(44,183)	(41,694)	(41,146)	(39,136)	(39,034)	(39,099)	(38,525)	(38,594)	(38,466)	(38,490)	(38,540)	(38,507)	(38,484)
Total Johnson & Johnson shareholders’ equity	79,277)	78,473)	78,109)	71,490)	70,158)	71,538)	70,020)	68,774)	71,228)	75,149)	70,869)	76,804)	74,599)	76,357)	74,709)	74,023)	70,272)	69,580)	65,834)	63,278)	64,473)	62,978)	61,294)
Equity attributable to non-controlling interest	—)	—)	—)	—)	—)	—)	—)	—)	—)	1,260)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)	—)
Total equity	79,277)	78,473)	78,109)	71,490)	70,158)	71,538)	70,020)	68,774)	71,228)	76,409)	70,869)	76,804)	74,599)	76,357)	74,709)	74,023)	70,272)	69,580)	65,834)	63,278)	64,473)	62,978)	61,294)
Total liabilities and shareholders’ equity	192,816)	193,389)	193,671)	180,104)	178,287)	181,088)	171,966)	167,558)	166,061)	191,686)	195,969)	187,378)	175,124)	177,724)	178,355)	182,018)	179,228)	176,440)	172,557)	174,894)	170,693)	158,380)	155,017)

The financial data over the covered periods reveals several noteworthy trends in the company's liabilities and equity structure. Current liabilities have exhibited fluctuations, with an overall upward trend peaking significantly in the early 2023 period before experiencing a notable decline thereafter. In particular, accounts payable and accrued rebates, returns, and promotions have generally increased, indicating possibly higher operating activity or changes in payment terms. Accrued liabilities and accrued compensation also showed peaks and moderate declines beyond 2021, suggesting adjustments in accrued expenses and employee-related costs.

Loans and notes payable displayed considerable volatility, with some sharp increases and decreases throughout the timeline, particularly a substantial spike in the final quarters of 2022 followed by a steep decline into 2023 and 2024. This behavior might reflect refinancing activities or varying short-term borrowing strategies.

Long-term debt, excluding the current portion, decreased steadily from 2020 through much of 2022 but then surged abruptly towards the end of the period, reaching the highest levels in the final years presented. This spike in long-term debt may imply increased financing for expansion, acquisitions, or other capital-intensive activities.

Deferred taxes on income varied throughout the periods, generally trending downward with intermittent rises, possibly influenced by changing tax regulations or timing differences between accounting and tax treatments. Similarly, long-term taxes payable declined markedly after early 2022, stabilizing at lower values, which may reflect tax planning outcomes or settlements.

Other liabilities experienced moderate fluctuations but showed a trend of increase approaching the later periods, hinting at emerging or gradually growing obligations. Employee-related obligations steadily declined from 2020 into 2023 and then stabilized with minor fluctuations, potentially due to workforce changes or benefit plan modifications.

Total liabilities reflect the combined effect of these movements. They peaked in early 2023, mainly driven by surges in loans and notes payable and current liabilities, then slightly decreased but remained elevated compared to the earlier periods.

On the equity side, common stock remained constant throughout the periods, indicating no new issuance or buybacks affecting the par value. Treasury stock increased significantly in cost toward the end of the timeline, suggesting substantial repurchases. Retained earnings and additional paid-in capital consistently grew over the years, with an accelerated increase after 2022, pointing to profitable operations and capital injections.

Accumulated other comprehensive loss showed erratic variation but overall remained negative, with some periods of improvement followed by worsening, reflecting fluctuations in unrealized gains or losses, possibly from foreign currency translations or marketable securities.

Total shareholders’ equity generally trended upward, with noticeable gains after 2022 despite some volatility, supported by increasing retained earnings and paid-in capital. Total liabilities and equity together maintained balance as expected, showing growth in the overall funding base of the company.

In summary, the data indicates a period of dynamic financial management with shifting debt structures, increased short-term liabilities in certain intervals, and strengthened equity positions marked by share repurchases and retained earnings growth. These patterns might suggest strategic repositioning, capital investments, and ongoing operational activity adjustments over the reviewed quarters.

Current Liabilities: Fluctuated with a general upward trend peaking in early 2023, then decreased.
Loans and Notes Payable: Highly volatile with a major spike in late 2022 followed by decline.
Long-Term Debt: Decreased through 2022 but surged sharply in final years.
Deferred and Long-Term Taxes Payable: Deferred taxes varied downward; long-term taxes payable dropped significantly after 2022.
Other Liabilities and Employee Obligations: Other liabilities increased towards later periods; employee obligations declined then stabilized.
Total Liabilities: Peaked in early 2023, remained elevated but showed minor decreases thereafter.
Common Stock and Treasury Stock: Common stock stable; treasury stock cost increased substantially indicating share repurchases.
Retained Earnings and Additional Paid-in Capital: Consistently grew with acceleration post-2022, demonstrating profitability and capital growth.
Accumulated Other Comprehensive Loss: Varied but remained negative, indicating fluctuating unrealized losses.
Total Shareholders’ Equity: Generally increased, supported by growth in retained earnings despite volatility in other comprehensive loss.

Download chart

Johnson & Johnson (NYSE:JNJ)

Balance Sheet: Liabilities and Stockholders’ Equity Quarterly Data

Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data